Vincerx Pharma logo

Vincerx Pharma Share Price Today

(NASDAQ: VINC)

Vincerx Pharma share price is $0.85 & ₹73.92 as on 6 Mar 2025, 2.30 'hrs' IST

$0.85

0.05

(6.75%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Vincerx Pharma share price in Dollar and Rupees. Guide to invest in Vincerx Pharma stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Vincerx Pharma, along with analyst recommendations, forecasts, and comprehensive financials.

Vincerx Pharma share price movements

  • Today's Low: $0.78
    Today's High: $0.91

    Day's Volatility :13.97%

  • 52 Weeks Low: $0.75
    52 Weeks High: $187.44

    52 Weeks Volatility :99.6%

Vincerx Pharma (VINC) Returns

PeriodVincerx Pharma IncIndex (Russel 2000)
3 Months
-81.11%
0.0%
6 Months
-94.67%
0.0%
1 Year
-99.43%
0.0%
3 Years
-99.11%
-11.6%

Vincerx Pharma (VINC) Key Statistics

in dollars & INR

Previous Close
$0.8
Open
$0.8
Today's High
$0.9067
Today's Low
$0.78
Market Capitalization
$10.5M
Today's Volume
$13.0K
52 Week High
$187.444
52 Week Low
$0.75
Revenue TTM
$0.0
EBITDA
$-29.9M
Earnings Per Share (EPS)
$-1.14
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-142.45%

How to invest in Vincerx Pharma Stock (VINC) from India?

It is very easy for Indian residents to invest directly in Vincerx Pharma from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Vincerx Pharma stock in both Indian Rupees (INR) and US Dollars (USD). Search for Vincerx Pharma or VINC on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Vincerx Pharma or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Vincerx Pharma shares which would translate to 1.023 fractional shares of Vincerx Pharma as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Vincerx Pharma, in just a few clicks!

Returns in Vincerx Pharma (VINC) for Indian investors in Rupees

The Vincerx Pharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Vincerx Pharma investment value today

Current value as on today

₹5,567

Returns

₹94,433

(-94.43%)

Returns from Vincerx Pharma Stock

₹99,395 (-99.4%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Vincerx Pharma (VINC)

-72.63%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Investment in Vincerx Pharma Shares from India has dropped by -72.63% over the past 30 days, indicating reduced transactional activity.

-81%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Vincerx Pharma Stock from India on INDmoney has decreased by -81% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Vincerx Pharma

  • SAGE RHINO CAPITAL LLC

    3.80%

  • Rock Springs Capital Management LP

    1.99%

  • Armistice Capital, LLC

    1.27%

  • Geode Capital Management, LLC

    0.54%

  • Rubric Capital Management LP

    0.26%

  • UBS Group AG

    0.21%

Analyst Recommendation on Vincerx Pharma

Buy

    88%Buy

    11%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Vincerx Pharma(by analysts ranked 0 to 5 stars)

Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
8
8
8
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Vincerx Pharma Stock (VINC)

What analysts predicted

Upside of 605.88%

Target:

$6.00

Current:

$0.85

Insights on Vincerx Pharma Stock (Ticker Symbol: VINC)

  • Price Movement

    In the last 7 days, VINC stock has moved down by -26.6%
  • VINC vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 161.6%
  • VINC vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 146.8%

Vincerx Pharma Technicals Summary

Sell

Neutral

Buy

Vincerx Pharma is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Vincerx Pharma (VINC) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Vincerx Pharma Inc logo
-50.31%
-94.67%
-99.43%
-99.11%
-99.8%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Vincerx Pharma Inc logo
NA
NA
NA
-0.73
-1.42
-0.66
NA
0.52
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Vincerx Pharma Inc logo
Buy
$10.5M
-99.8%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Vincerx Pharma

Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. The company is developing enitociclib, a cyclin-dependent kinase-9 inhibitor that is in Phase 1 clinical trials for treating patients with relapsed and refractory leukemia and lymphoid malignancies, as well as solid tumors and non-Hodgkin lymphoma; and VIP236, a small molecule drug conjugate that is in Phase 1 clinical trials to treat advanced or metastatic solid tumors. Its product candidates also include VIP943 in Phase 1 clinical trials for the treatment of relapsed/refractory acute myeloid leukemia, myelodysplastic syndrome, and B-cell acute lymphoblastic leukemia; and VIP924 in preclinical studies for the treatment of B-cell malignancies. Vincerx Pharma, Inc. was founded in 2019 and is based in Palo Alto, California.
Organization
Vincerx Pharma
Employees
42
CEO
Dr. Raquel E. Izumi Ph.D.
Industry
Miscellaneous

Management People of Vincerx Pharma

NameTitle
Dr. Ahmed M. Hamdy M.D.
Co-Founder & Chairman
Dr. Raquel E. Izumi Ph.D.
Co-Founder, Acting CEO, Secretary & Director
Mr. Tom C. Thomas J.D.
Founder, General Counsel & Chief Legal Officer
Dr. John C. Byrd M.D.
Founder & Chairman of Scientific Advisory Board
Mr. Kevin Haas
Acting CFO, VP of Finance & Corporate Controller
Dr. Hans-Georg Lerchen Ph.D.
Chief Scientific Officer
Ms. Karen Quarford M.B.A.
Vice President of Quality Operations & Compliance
Ms. Melissa Merrick SPHR
Senior Director of People & Culture and Head of Human Resource
Dr. Beatrix Stelte-Ludwig Ph.D.
Executive Chief Development Officer
Mr. Steven H. Bloom R.Ph.
Chief Business Officer

Important FAQs about investing in VINC Stock from India :

What is Vincerx Pharma share price today?

Vincerx Pharma share price today stands at $0.85, Open: $0.80 ; Previous Close: $0.80 ; High: $0.91 ; Low: $0.78 ; 52 Week High: $187.44 ; 52 Week Low: $0.75.

The stock opens at $0.80, after a previous close of $0.80. The stock reached a daily high of $0.91 and a low of $0.78, with a 52-week high of $187.44 and a 52-week low of $0.75.

Can Indians buy Vincerx Pharma shares?

Yes, Indians can invest in the Vincerx Pharma (VINC) from India.

With INDmoney, you can buy Vincerx Pharma at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Vincerx Pharma at zero transaction cost.

How can I buy Vincerx Pharma shares from India?

It is very easy to buy Vincerx Pharma from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Vincerx Pharma (VINC) be purchased?

Yes, you can buy fractional shares of Vincerx Pharma with INDmoney app.

What are the documents required to start investing in Vincerx Pharma stocks?

To start investing in Vincerx Pharma, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Vincerx Pharma Stock (VINC)?

Today’s highest price of Vincerx Pharma (VINC) is $0.91.

Today’s lowest price of Vincerx Pharma (VINC) is $0.78.

What is today's market capitalisation of Vincerx Pharma?

Today's market capitalisation of Vincerx Pharma VINC is 10.5M

What is the 52 Week High and Low Range of Vincerx Pharma Stock (VINC)?

  • 52 Week High

    $187.44

  • 52 Week Low

    $0.75

What are the historical returns of Vincerx Pharma (VINC)?

  • 1 Month Returns

    -50.31%

  • 3 Months Returns

    -94.67%

  • 1 Year Returns

    -99.43%

  • 5 Years Returns

    -99.8%

Who is the Chief Executive Officer (CEO) of Vincerx Pharma ?

Dr. Raquel E. Izumi Ph.D. is the current Chief Executive Officer (CEO) of Vincerx Pharma.